Ineos Grenadiers respond to Richard Freeman guilty verdict
Team says it's clear Freeman "fell short of the ethical standards required of him as a doctor" but denied any wrongdoing
Ineos Grenadiers have responded to the guilty verdict handed down to their former doctor, Richard Freeman, that he ordered banned testosterone ‘knowing or believing’ it was to help enhance the performance of a rider.
The Medical Practitioners Tribunal Service (MPTS) on Friday (March 12) found that in 2011 Freeman ordered Testogel to the British Cycling and Team Sky Manchester HQ “knowing or believing it was to be administered to an athlete to improve their athletic performance." No rider has been identified but Freeman has subsequently been suspended by UK Anti-Doping on two charges.
Dr Freeman worked for Team Sky (now Ineos Genadiers) between 2009 and 2015, and British Cycling from 2009 to 2017 when he stepped down from his role due to ill health. His medical tribunal, originally scheduled for February 2019, started in November 2019 after he was accused by the General Medical Council (GMC) of ordering 30 sachets of Testogel and it has dragged on since.
Ineos on Friday afternoon released a statement saying that it is "very clear" that Freeman "fell short of the ethical standards required of him as a doctor" but said they did not believe there was evidence to support the finding that any athlete used Testogel or any other performance enhancing substances.
"The Team fully supports the work of the GMC and it is very clear from their report that Richard Freeman fell short of the ethical standards required of him as a doctor and acted dishonestly," the Ineos statement read.
"However the Team does not believe that any athlete ever used or sought to use Testogel or any other performance enhancing substance. No evidence has been provided that this ever happened or that there has been any wrongdoing by any athlete at any point.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
"We will continue to give our full support and co-operation to UKAD, as we have done throughout this process, as they continue to investigate his conduct. We will not be making any further comment."
Freeman had already admitted 18 of the 22 charges brought against him by the tribunal before today's verdict, including purchasing the banned Testogel, lying to the UK Anti-Doping Agency (UKAD), and keeping haphazard records.
Of the four contested charges relating to the delivery of the banned testosterone to British Cycling and Team Sky Manchester HQ in June 2011, Freeman was cleared of one – that he ordered Testogel when he “knew it was not clinically indicated for the non-athlete member of staff”.
The hearing will resume on March 17 where the tribunal will decide if Freeman’s “fitness to practice is impaired”.
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Follow on Twitter: @richwindy
Richard is digital editor of Cycling Weekly. Joining the team in 2013, Richard became editor of the website in 2014 and coordinates site content and strategy, leading the news team in coverage of the world's biggest races and working with the tech editor to deliver comprehensive buying guides, reviews, and the latest product news.
An occasional racer, Richard spends most of his time preparing for long-distance touring rides these days, or getting out to the Surrey Hills on the weekend on his Specialized Tarmac SL6 (with an obligatory pub stop of course).
-
USA Cycling unveils 2025 National Championship schedule with 17 chances to claim the Stars and Stripes jersey
From cycling eSports in February to cyclocross in December, here are the dates and locations for the 2025 season
By Anne-Marije Rook Published
-
Tech of the week: A shockingly expensive steel bike from Colnago, a surprisingly affordable carbon bike from Pinarello, DT Swiss energises our cycling lives and Pog's bars are now yours to buy
Colnago's Steelnova is a thing of beauty but you'll pay for the pleasure, while Pinarello's F1 is an inexpensive gateway to the brand. DT Swiss enters the dynamo hub market and Enve brings Pog's cockpit to market
By Luke Friend Published
-
Ineos Grenadiers hire new head of engineering as reshuffle continues
Former British Cycling lead, Dr Billy Fitton, is the latest of a handful of new appointments within the British squad
By Tom Davidson Published
-
Overachiever: Cameron Wurf competed in the Amstel Gold, La Flèche Wallonne and an Ironman, all in just eight days
Cameron Wurf is both a member of Team Ineos Grenadiers and an accomplished professional long course triathlete who has racked up numerous World Tour and Ironman race finishes across his career.
By Kristin Jenny Published
-
‘I feel lucky to be alive’: Magnus Sheffield speaks for the first time about Gino Mäder’s fatal crash
The American describes what he saw at the Tour de Suisse, eight months after the tragedy
By Tom Davidson Published
-
Tom Pidcock: Tour of Britain route 'not really ideal for me'
Brit says he wants to win home stage race, even if the course plays in Wout van Aert's favour
By Tom Davidson Published
-
This 39-year-old INEOS Grenadiers rider moonlights as a pro triathlete
A Jack of all trades, Cameron Wurf is a domestique for INEOS Grenadiers professional cycling team, but doubles as a successful pro triathlete.
By Kristin Jenny Published
-
Ineos Grenadiers' only female rider Pauline Ferrand-Prévot eyes road return
Mountain bike legend could be back in the peloton next year
By Tom Davidson Published
-
Egan Bernal has nose operation to help 'air passage' ahead of 2023
Procedure not thought to be connected to the life-threatening crash which affected Colombian last year
By Adam Becket Published
-
Tweets of the week: Ineos Grenadiers' three wise men, team jersey déjà vu and World Cup celebrations by bike
Here's our social media round-up, featuring a cycling all-star nativity
By Tom Davidson Published